UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients

PloS one, 2021-11, Vol.16 (11), p.e0260155-e0260155

2021

Volltextzugriff (PDF)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1

Scientific reports, 2021-11, Vol.11 (1), p.22164-12, Article 22164

2021

Volltextzugriff (PDF)

Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1

Vaccine, 2013-12, Vol.31 (52), p.6194-6200

2013

Volltextzugriff (PDF)

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

PloS one, 2015-09, Vol.10 (9), p.e0138722-e0138722

2015

Volltextzugriff (PDF)

Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame

PloS one, 2012-05, Vol.7 (5), p.e36506

2012

Volltextzugriff (PDF)

Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography

Vaccine, 2014-05, Vol.32 (21), p.2487-2492

2014

Volltextzugriff (PDF)

Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon

Journal of Virology, 2000-12, Vol.74 (24), p.11566-11573

2000

Volltextzugriff (PDF)

Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein

Journal of Virology, 2000-09, Vol.74 (17), p.7989-7996

2000

Volltextzugriff (PDF)

Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication

Journal of Virology, 2000-07, Vol.74 (13), p.6203-6206

2000

Volltextzugriff (PDF)

Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma

Pigment cell and melanoma research, 2011-08, Vol.24 (4), p.656-665

2011

Volltextzugriff (PDF)

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

PloS one, 2015, Vol.10 (11), p.e0143269-e0143269

2015

Volltextzugriff (PDF)

Influenza A and B Viruses Expressing Altered NS1 Proteins: A Vaccine Approach

Proceedings of the National Academy of Sciences - PNAS, 2000-04, Vol.97 (8), p.4309-4314

2000

Volltextzugriff (PDF)

Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice

PloS one, 2012-06, Vol.7 (6), p.e39921-e39921

2012

Volltextzugriff (PDF)

Establishment of a Chimeric, Replication-Deficient Influenza A Virus Vector by Modulation of Splicing Efficiency

Journal of Virology, 2011-03, Vol.85 (5), p.2469-2473

2011

Volltextzugriff (PDF)

Antimycotic-Antibiotic Amphotericin B Promotes Influenza Virus Replication in Cell Culture

Journal of Virology, 2011-11, Vol.85 (21), p.11139-11145

2011

Volltextzugriff (PDF)

Haptische Zugriffe auf Gegenstände – eine Chance für historisches Lernen?: Fachwissenschaftliche, fachdidaktische und pädagogische Impulse

1, 2021

Volltextzugriff (PDF)

Transfectant Influenza A Viruses with Long Deletions in the NS1 Protein Grow Efficiently in Vero Cells

Journal of Virology, 1998-08, Vol.72 (8), p.6437-6441

1998

Volltextzugriff (PDF)

Relevanz der Antike im Sachunterricht: Eine Frage von Lebensweltbezug, Standort und Themenwahl

Must, Thomas

2022

Volltextzugriff (PDF)

Effects of Influenza A Virus NS1 Protein on Protein Expression: the NS1 Protein Enhances Translation and Is Not Required for Shutoff of Host Protein Synthesis

Journal of Virology, 2002-02, Vol.76 (3), p.1206-1212

2002

Volltextzugriff (PDF)

Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1

Vaccine, 2019-06, Vol.37 (28), p.3722-3729

2019

Volltextzugriff (PDF)

Influenza virus vector iNS1 expressing bovine papillomavirus 1

PloS one, 2021-11, Vol.16 (11), p.e0260155

2021

Volltextzugriff (PDF)

Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (3), p.1658-1663

2006

Volltextzugriff (PDF)

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

AIDS (London), 1996-06, Vol.10 (6), p.587-594

1996

Volltextzugriff (PDF)

A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication-Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1

The Journal of infectious diseases, 2010-02, Vol.201 (3), p.354-362

2010

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(113)
Deutsch
(23)
Japanisch
(16)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Life Sciences & Biomedicine
(71)
Humans
(52)
Animals
(39)
Virology
(28)
Biological And Medical Sciences
(19)
Influenza A Virus
(18)
Mice
(18)
Viruses
(18)
Cell Line
(16)
Female
(16)
Influenza
(15)
Microbiology
(14)
Vero Cells
(14)
Cercopithecus Aethiops
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Influenza A Virus - Genetics
(13)
Oncology
(13)
Vaccines
(13)
Viral Nonstructural Proteins - Genetics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1

Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame

Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography

Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon

Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein

Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1

Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication

Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

Influenza A and B Viruses Expressing Altered NS1 Proteins: A Vaccine Approach

Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice

Establishment of a Chimeric, Replication-Deficient Influenza A Virus Vector by Modulation of Splicing Efficiency

Antimycotic-Antibiotic Amphotericin B Promotes Influenza Virus Replication in Cell Culture

Haptische Zugriffe auf Gegenstände – eine Chance für historisches Lernen?: Fachwissenschaftliche, fachdidaktische und pädagogische Impulse

Transfectant Influenza A Viruses with Long Deletions in the NS1 Protein Grow Efficiently in Vero Cells

Relevanz der Antike im Sachunterricht: Eine Frage von Lebensweltbezug, Standort und Themenwahl

Effects of Influenza A Virus NS1 Protein on Protein Expression: the NS1 Protein Enhances Translation and Is Not Required for Shutoff of Host Protein Synthesis

Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1

Influenza virus vector iNS1 expressing bovine papillomavirus 1

Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication-Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1

Suchergebnisse filtern